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Abstract
The mechanisms implicated in the pathology of Huntington’s disease (HD) remain not completely 
understood, although dysfunction of mitochondrial oxidative metabolism and Ca2+ handling have 
been suggested as contributing factors. However, in our previous studies with mitochondria 
isolated from the whole brains of HD mice, we found no evidence for defects in mitochondrial 
respiration and Ca2+ handling. In the present study, we used the YAC128 mouse model of HD to 
evaluate the effect of mHtt on respiratory activity and Ca2+ uptake capacity of mitochondria 
isolated from the striatum, the most vulnerable brain region in HD. Isolated, Percoll-gradient 
purified striatal mitochondria from YAC128 mice were free of cytosolic and ER contaminations, 
but retained attached mHtt. Both nonsynaptic and synaptic striatal mitochondria isolated from 
early symptomatic 2-month-old YAC128 mice had similar respiratory rates and Ca2+ uptake 
capacities compared with mitochondria from wild-type FVB/NJ mice. Consistent with the lack of 
difference in mitochondrial respiration, we found that the expression of several nuclear-encoded 
proteins in striatal mitochondria was similar between wild-type and YAC128 mice. Taken together, 
our data demonstrate that mHtt does not alter respiration and Ca2+ uptake capacity in striatal 
mitochondria isolated from YAC128 mice, suggesting that respiratory defect and Ca2+ uptake 
deficiency most likely do not contribute to striatal pathology associated with HD.
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1. Introduction
Huntington’s disease (HD) is a fatal neurodegenerative disorder characterized by a 
progressive decline of motor and cognitive functions (Roze et al., 2010). An increase in the 
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number of CAG repeats to more than 35 in exon 1 of the htt gene has been proposed to be 
the genetic alteration leading to HD (MacDonald et al., 1993). This mutation leads to the 
expression of the mutated huntingtin protein (mHtt) which harbors an elongated 
polyglutamine (polyQ) domain near the N-terminus (MacDonald et al., 1993). Although the 
mutation linked to HD was identified more than 20 years ago, the precise mechanism of 
deleterious action of mHtt is still unclear. Among other mechanisms, bioenergetic 
abnormalities and altered mitochondrial Ca2+ handling have been suggested as potential 
contributors to neuronal dysfunction in HD (Giacomello et al., 2011; Polyzos and 
McMurray, 2016).
Earlier findings suggested abnormalities in mitochondrial respiration and defects in Ca2+ 
handling in mitochondria from HD mouse and cell models (Tabrizi et al., 2000; Damiano et 
al., 2013; Aidt et al., 2013; Panov et al., 2002; Choo et al., 2004; Lim et al., 2008). In our 
previous studies, we tested the possible deleterious effects of mHtt on mitochondrial 
oxidative metabolism and Ca2+ handling using isolated nonsynaptic and synaptic 
mitochondria from the whole brain of HD mice (Pellman et al., 2015; Hamilton et al., 2015; 
Hamilton et al., 2016). We tested mitochondrial functions using transgenic YAC128 mice, 
which express full-length human mHtt, and R6/2 mice, which express the N-terminal 
fragment of human mHtt (Slow et al., 2003). Despite our efforts, we did not find evidence 
for mitochondrial dysfunction using nonsynaptic and synaptic mitochondria isolated from 
both YAC128 and R6/2 mouse models of HD. In HD, different brain regions have different 
susceptibility to degeneration with striatum being most vulnerable, and the hippocampus and 
cerebellum remaining practically unaffected (Vonsattel and DiFiglia, 1998). Consequently, 
the use of mitochondria isolated from whole mouse brains could be a reason for our failure 
to detect mitochondrial dysfunction in HD mice.
Marked atrophy of the caudate nucleus and putamen represent the first features of brain 
pathology in HD (Vonsattel et al., 1985). Within the striatum, the GABAergic medium spiny 
neurons, which comprise about 95% of all neurons in the striatum, are the cell type that is 
most susceptible to degeneration (Han et al., 2010). Striatal loss is discernable in HD 
patients even before classical choreiform signs of HD appear (Bates et al., 2015). In this 
study, investigators used magnetic resonance imaging applied to clinically diagnosed 
prodromal HD patients and found that striatal atrophy precedes the onset of motor 
symptoms. Similar to the pathology found in HD patients, YAC128 mice display decreased 
number of striatal neurons and diminished striatal volume compared to wild-type mice 
(Slow et al., 2003; Pouladi et al., 2012). It is conceivable that mitochondrial defects 
contribute to neuronal dysfunction and eventual cell death of striatal neurons. In the present 
study, we assessed the respiratory activity and Ca2+ handling in mitochondria isolated 
exclusively from the striatal tissues of YAC128 mice. Consistent with our previously 
reported data, we found no evidence of mHtt-induced impairment of respiration and Ca2+ 
handling in striatal nonsynaptic and synaptic mitochondria isolated from brains of YAC128 
mice.
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2. Materials and Methods
2.1 Materials
Pyruvate, malate, succinate, glutamate, ADP, and 2,4-dinitrophenol were purchased from 
Sigma (St. Louis, MO). Bovine serum albumin (BSA), free from free fatty acids, was from 
MP Biomedicals (Irvine, CA).
2.2 Animals and genotyping
All procedures with animals were performed in accordance with the Institutional Animal 
Care and Use Committee approved protocol. All efforts were made to minimize animal 
suffering, to reduce the number of animals used, and to utilize alternatives to in vivo 
techniques, if available. All animal experiments were carried out in accordance with the 
National Institutes of Health guide for the care and use of Laboratory animals (NIH 
Publications No. 80-23, revised 1978). Transgenic YAC128 mice as well as wild-type 
FVB/NJ mice were purchased from Jackson Laboratories (Bar Harbor, ME) and breeding 
colonies were established in the Laboratory Animal Resource Center at Indiana University 
School of Medicine, Indianapolis, IN. YAC128 mice express full-length human mHtt, 
including upstream and downstream regulatory elements, containing a polyglutamine 
(polyQ) region of 128 glutamines. Female FVB/NJ mice were bred with male YAC128 
mice. Mice were housed under standard conditions with free access to food and water. In all 
of our experiments, we used early symptomatic 2-month-old YAC128 mice and FVB/NJ 
littermates. Every animal used for experiments was genotyped by PCR assay on tail DNA. 
PCR of tail DNA was carried out according to the protocol furnished by Jackson 
Laboratories with oligonucleotide primers oIMR6533 (GGCTGAGGAAGCTGAGGAG) 
and TmoIMR1594 (CCGCTCAGGTTCTGCTTTTA) (Invitrogen, Carlsbad, CA). The PCR 
reaction mixture was prepared with 1μL DNA template and 24μL Platinum PCR SuperMix 
(Invitrogen) containing 0.39μM of each primer for a total reaction volume of 25μL. Cycling 
conditions were 5 min at 95°C, 35 cycles of 30 s at 95°C, 30 s at 56°C, 60 s at 72°C, 10 min 
at 72°C. PCR reaction products were visualized on a 1.2% agarose gel run at 100 V for 60 
min with Tris–acetate–EDTA running buffer containing 1X GelRedTM Nucleic Acid Gel 
Stain (Biotium, Hayward, CA).
2.3 Isolation of nonsynaptic and synaptic striatal mitochondria
Percoll gradient-purified striatal nonsynaptic and synaptic mitochondria from 2-month-old 
YAC128 and wild-type FVB/NJ littermates were isolated as previously described 
(Brustovetsky et al., 2002; Shalbuyeva et al., 2007). HD affects men and women equally 
(Novak and Tabrizi, 2010); therefore, throughout this study mice of both sexes were used. 
Brains from both males and females were pooled for the mitochondrial isolation. To prepare 
nonsynaptic mitochondria, the striata of nine FVB/NJ and YAC128 mice each were used for 
a single isolation procedure and for synaptic mitochondria 15 mice of each strain were used 
for a single isolation procedure (Brustovetsky et al., 2003). It was previously proposed that 
BSA may preclude mHtt from binding to the mitochondrial outer membrane (Panov et al., 
2003), therefore, where indicated, BSA was omitted from solutions used in isolation 
procedures and from incubation medium. However, in our previous study, we showed that 
BSA does not displace mHtt from mitochondria (Pellman et al., 2015). Consequently, where 
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indicated 0.1% BSA (free from fatty acids) was used in isolation solutions and incubation 
medium.
2.4 Immunoblotting
Brain homogenates, cytosolic fractions, and striatal isolated mitochondria that were 
previously treated with Proteinase Inhibitor Cocktail (Roche, Indianapolis, IN) were 
solubilized by incubation in NuPAGE LDS sample buffer (Invitrogen) plus a reducing agent 
at 70°C for 10 min. Either Bis-Tris Mops gels (4–12%, Invitrogen) or Tris-Acetate gels (3–
8%, Invitrogen) were used to separate proteins by electrophoresis. Either 10 or 40μg protein 
per lane was loaded. Following electrophoresis, proteins were transferred to Hybond-ECL 
nitrocellulose membrane (Amersham Biosciences, Piscataway, NJ). Blots were incubated for 
1 hour at room temperature in blocking solution of either 5% milk or 5% BSA dissolved in 
phosphate-buffered saline, pH 7.2, and 0.15% Triton X-100. Then, blots were incubated with 
one of the following primary antibodies: mouse monoclonal anti-polyQ 1C2 (mAB 1574, 
1:3000, Millipore, Temecula, CA), rabbit polyclonal anti-calnexin (1:1200, Abcam, 
Cambridge, MA), rabbit monoclonal anti-MEK1/2 (1:2000, Pierce, Rockford, IL), mouse 
monoclonal anti-Complex I 39 kDa subunit (1:1000, Invitrogen), mouse monoclonal anti-
Complex II 30 kDa subunit (1:1000, Invitrogen), mouse monoclonal anti-Complex II 70 kDa 
subunit (1:1000, Invitrogen), mouse monoclonal anti-aconitase 2 (1:1000, Abcam), rabbit 
polyclonal anti-manganese superoxide dismutase (MnSOD, 1:2000, Millipore), mouse 
monoclonal anti-ATP synthase α subunit (1:1000, Abcam), mouse monoclonal anti-CyD 
antibody (1:500, Calbiochem, San Diego, CA), mouse monoclonal anti-Complex IV 
(1:2500, Invitrogen), rabbit polyclonal anti-VDAC1 (1:1000, Calbiochem). Blots were 
incubated with either goat anti-mouse or goat anti-rabbit IgG (1:25000 or 1:20000, 
respectively) coupled with horseradish peroxidase (Jackson ImmunoResearch Laboratories, 
West Grove, PA) and developed with Supersignal West Pico chemiluminescent reagents 
(Pierce). Molecular mass markers See Blue Plus 2 Standards (Invitrogen) and HiMark Pre-
stained High Molecular Weight Protein Standards (Invitrogen) were used for molecular mass 
determination. NIH ImageJ 1.48v software (http://rsb.info.nih.gov//ij) was used for 
densitometry.
2.5 Mitochondrial respiration
Mitochondrial respiration was measured with a Clark-type oxygen electrode during 
continuous stirring in a tightly sealed 0.4 ml chamber heated to 37°C. Experiments were 
performed in the standard incubation medium containing 125 mM KCl, 0.5 mM MgCl2, 3 
mM KH2PO4, 10 mM Hepes, pH 7.4, 10μM EGTA supplemented with either 3mM pyruvate 
plus 1 mM malate or 3 mM succinate plus 3 mM glutamate. Glutamate was used in 
experiments with succinate to prevent oxaloacetate-mediated inhibition of succinate 
dehydrogenase (Wojtczak, 1969; Brustovetsky and Dubinsky, 2000). Respiratory rates were 
calculated from the slopes of the oxygen consumption traces.
2.6 Mitochondrial Ca2+ uptake capacity
Mitochondrial Ca2+ uptake was measured under continuous stirring in a 0.3 ml chamber 
equipped with a miniature Ca2+-selective electrode and heated to 37°C. Uptake of Ca2+ by 
mitochondria is indicated by a decrease in external Ca2+ in the chamber. The experiments 
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were performed in the standard incubation medium supplemented with either 3 mM 
pyruvate plus 1 mM malate or 3 mM succinate plus 3 mM glutamate. As described 
previously, the incubation medium was also supplemented with 0.1 mM ADP and 1μM 
oligomycin in these experiments (Chalmers and Nicholls, 2003). Ca2+ was applied to 
isolated mitochondria in the form of 10μM CaCl2 pulses.
2.7 Statistics
Statistical analysis of the experimental results consisted of unpaired t-test or one-way 
ANOVA followed by Bonferroni’s post hoc test (GraphPad Prism® 4.0, GraphPad Software 
Inc., SanDiego, CA, USA). Data are shown as mean ± SEM of several independent 
experiments.
3. Results
3.1. Clasping phenotype of early symptomatic YAC128 mice
In this study, we used YAC128 mice which express full-length human mHtt with an 
expanded glutamine tract of 128 repeats under control of the endogenous human promoter 
(Slow, 2003). The mice ranged in age from 8–10 weeks and already showed signs of motor 
dysfunction manifested as clasping of the fore- and hind-limbs when suspended by the tail 
(Fig. 1A, B). This clasping behavior is characteristic of HD mice and has been previously 
reported (Mangiarini et al., 1996; Reddy et al., 1999). Since the mice exhibited this 
phenotype, it suggests that if altered mitochondrial respiration or Ca2+ handling contributed 
to such behavioral aberrations, we should be able to detect such defects in brain 
mitochondria isolated from these mice. For all experiments, age-matched genetic 
background FVB/NJ mice were used as control. Before all experiments, every mouse was 
genotyped by PCR on tail DNA to confirm the presence or absence of the transgene (Fig. 
1C).
3.2. Expression of mHtt in striatal mitochondria and purity of mitochondrial preparations
Nonsynaptic mitochondria were derived from neuronal somata and glial cells whereas 
synaptic mitochondria were isolated from neuronal synaptic terminals and, therefore, were 
of exclusively neuronal origin. Figure 2A, B shows the absence of MEK1/2, a cytosolic 
marker, and calnexin, an endoplasmic reticulum (ER) marker, in mitochondrial fractions, 
suggesting the absence of cytosolic and ER contaminations. On the other hand, 
mitochondrial fractions contained augmented levels of Complex II, 70 kDa subunit (CII, 70) 
indicating mitochondrial enrichment in these fractions. Mitochondria from YAC128, but not 
FVB/NJ mice, contained mHtt detected with mouse monoclonal mHtt-specific antibody 1C2 
(1:1000, mAb 1574, Millipore, Temecula, CA) that recognizes the polyglutamine stretch of 
the protein (Fig. 2C). This is consistent with our previous data (Hamilton et al., 2015) and 
with results from others (Choo et al., 2004). Huntingtin protein and its mutated form, mHtt, 
reside in the cytosol (Bates et al., 2015) and, therefore, the presence of mHtt in the 
mitochondrial fraction could be due to cytosolic contamination. However, because 
mitochondrial fractions did not contain detectable amounts of cytosolic contamination, mHtt 
present in mitochondrial fractions (Fig. 2C) was unlikely to be the result of cytosolic 
contamination (Fig. 2A, B). Thus, in our study we used striatal nonsynaptic and synaptic 
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mitochondria which were essentially free from cytosolic and ER contaminations and 
contained mHtt attached to mitochondria.
3.3. Respiration of nonsynaptic and synaptic striatal mitochondria from YAC128 mice
In our initial experiments, we used striatal nonsynaptic mitochondria fueled with 3 mM 
pyruvate and 1 mM malate, a combination of Complex I-linked substrates. Mitochondrial 
respiratory rates were measured under various conditions: basal mitochondrial respiration in 
the presence of only substrates (V2), ADP-stimulated respiration (V3, 300μM ADP), 
respiration following ADP depletion (V4), and maximal, 2,4-dinitrophenol (2,4-DNP)-
stimulated respiration (VDNP, 60μM 2,4-DNP). Earlier, it was reported that the functional 
difference between mitochondria from HD and wild-type animals could be reliably detected 
only in the absence of BSA (Panov et al., 2003). In the aforementioned study, BSA 
eliminated the difference and it was proposed that BSA displaces mHtt from the 
mitochondrial outer membrane. Consequently, BSA was omitted from all isolation and 
incubation solutions in our experiments shown in Figure 3. In these experiments, striatal 
mitochondria isolated from YAC128 and FVB/NJ mice had similar respiratory rates under 
every experimental condition.
Previously, it was shown that inhibition of Complex II with 3-nitropropionic acid 
recapitulated HD pathology in animals (Brouillet et al., 1999) and it was demonstrated that 
activity of Complex II is decreased in striatum of HD patients and in HD mouse striatal 
neurons (Benchoua et al., 2006). Correspondingly, in our subsequent experiments, we used 3 
mM succinate as a mitochondrial substrate in combination with 3 mM glutamate to remove 
oxaloacetate via transamination reaction and thus prevent oxaloacetate-mediated inhibition 
of Complex II (Wojtczak, 1969; Brustovetsky and Dubinsky, 2000). In addition, the 
incubation medium was supplemented with 0.1% BSA (free from fatty acids) to preserve 
mitochondrial integrity and improve mitochondrial functionality (Lai and Clark, 1989). In 
our previous study, we found that incubation of isolated mitochondria with 0.1% BSA failed 
to displace mHtt from the organelles (Pellman et al., 2015) and, therefore, we expected to 
detect mHtt effects on mitochondria despite the presence of BSA. In these experiments, we 
used nonsynaptic and synaptic mitochondria isolated from striata of YAC128 and FVB/NJ 
mice. Similar to our previously described experiments (Fig. 3), we did not find any 
difference in respiratory activity between mitochondria from YAC128 and wild-type 
FVB/NJ mice (Fig. 4).
3.4. Expression of nuclear-encoded proteins in mitochondria from YAC128 and wild-type 
mice
Recently, inhibition of protein import machinery in mitochondria from HD mice was 
reported and suggested to be a possible cause of bioenergetic deficit in HD (Yano et al., 
2014). The decrease in the levels of nuclear-encoded mitochondrial proteins seems to be a 
logical consequence of inhibition of mitochondrial import into mitochondria. However, this 
was not tested in the recent study (Yano et al., 2014). In our previous work with 
mitochondria isolated from the whole brain of YAC128 and wild-type FVB/NJ mice we did 
not find any difference in expression of nuclear-encoded proteins in mitochondria isolated 
from the whole brains (Hamilton et al., 2015). In the present study, we evaluated the levels 
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of protein expression in striatal nonsynaptic and synaptic mitochondria from YAC128 and 
FVB/NJ mice using immunoblotting followed by densitometry (Fig. 5). In these 
experiments, we did not find a difference in expression of randomly chosen nuclear-encoded 
proteins located in the inner membrane or matrix of mitochondria from YAC128 and 
FVB/NJ mice. We also did not find a difference in expression of VDAC1, a protein of the 
mitochondrial outer membrane.
3.5. Ca2+ uptake capacity of striatal nonsynaptic and synaptic mitochondria from YAC128 
and wild-type mice
Mitochondrial Ca2+ uptake plays an essential role in removal of excessive Ca2+ from the 
cytosol (Bernardi, 1999) and therefore is essential for maintenance of Ca2+ homeostasis in 
the cell and for cell survival (Bernardi and Rasola, 2007). Ca2+ accumulation in 
mitochondria is restricted by induction of the mitochondrial permeability transition pore that 
depolarizes mitochondria and thereby limits their ability to accumulate additional Ca2+ 
(Bernardi, 1999). Earlier, it was reported that mitochondria from HD mouse and cell models 
have decreased Ca2+ uptake capacity compared with mitochondria from wild-type animals 
and cells (Panov et al., 2002; Milakovic et al., 2006; Lim et al., 2008; Gellerich et al., 2008). 
However, recently we assessed Ca2+ uptake capacity in mitochondria isolated from the 
whole brains of YAC128 and R6/2 mice and did not find a difference compared to 
mitochondria from corresponding age-matched wild-type animals (Pellman et al., 2015; 
Hamilton et al., 2016). In the present study, we evaluated Ca2+ uptake capacity in striatal 
mitochondria from YAC128 and their genetic background FVB/NJ mice. We used 
nonsynaptic mitochondria incubated without BSA and fueled with a combination of 3 mM 
pyruvate and 1 mM malate or with a combination of 3 mM succinate and 3 mM glutamate 
(Fig. 6A, B). In both cases, Ca2+ uptake capacities of mitochondria from YAC128 and 
FVB/NJ mice were similar. In the latter case, supplementing incubation medium with BSA 
significantly increased Ca2+ uptake capacity of mitochondria from both YAC128 and 
FVB/NJ mice without revealing any difference between mitochondria from these animals 
(Fig. 6C). Figure 6D shows statistical analysis of these experiments.
Next, we tested striatal synaptic mitochondria from YAC128 and FVB/NJ mice (Fig. 7). 
Mitochondria were fueled with a combination of 3 mM succinate and 3 mM glutamate and 
incubated without BSA. We did not find a difference in Ca2+ uptake capacity in striatal 
synaptic mitochondria from YAC128 and FVB/NJ mice (Fig. 7A). Addition of BSA to the 
incubation medium significantly increased Ca2+ uptake capacity in mitochondria from both 
YAC128 and FVB/NJ mice (Fig. 7B). Interestingly, under these conditions striatal synaptic 
mitochondria from YAC128 mice accumulated even more Ca2+ than mitochondria from 
wild-type animals. Figure 7C shows statistical analysis of these experiments. Taken together, 
evaluation of mitochondrial Ca2+ uptake capacity did not provide evidence for defects in 
Ca2+ handling by striatal mitochondria from YAC128 mice.
4. Discussion
The role of mitochondrial dysfunction in HD pathogenesis has been investigated in many 
studies with contradictory results (Brustovetsky, 2016). This controversy may arise from 
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variations in experimental models of HD and techniques used in these studies. Nevertheless, 
all of these studies may provide important information regarding possible mechanisms 
involved in HD pathogenesis. In our recent studies, we showed that nonsynaptic and 
synaptic mitochondria isolated from whole brains of YAC128 and R6/2 mice have similar 
respiratory rates and Ca2+ uptake capacities compared to mitochondria from corresponding 
genetic background animals: FVB/NJ and B6CBAF1/J mice, respectively (Pellman et al., 
2015; Hamilton et al., 2015; Hamilton et al., 2016). The results produced in experiments 
with isolated mitochondria were substantiated in studies with striatal neurons in culture. In 
HD, striatum is the most vulnerable brain region whereas hippocampus and cerebellum 
remain practically intact (Vonsattel and DiFiglia, 1998). The use of mitochondria isolated 
from whole brains was a limitation of our previous studies because contribution from 
mitochondria from unaffected brain regions may have obscured deficiencies of striatal 
mitochondria. In the present study, we used nonsynaptic and synaptic mitochondria isolated 
exclusively from striata of 8–10 week-old YAC128 and FVB/NJ mice. The results produced 
in the present study are consistent with our data reported previously (Pellman et al., 2015; 
Hamilton et al., 2015; Hamilton et al., 2016). We did not find evidence for alterations in 
expression of nuclear-encoded mitochondrial proteins and for impairment of mitochondrial 
respiration and Ca2+ uptake capacity in striatal mitochondria from YAC128 mice compared 
to mitochondria from FVB/NJ mice. These findings argue against mitochondrial dysfunction 
as a contributing factor in HD pathogenesis.
Relatively simple and straightforward experiments with isolated mitochondria provide a 
unique opportunity to examine the effect of mHtt on mitochondrial functions under well-
defined conditions. The fact that brain mitochondria isolated from HD mouse models retain 
attached mHtt and the possibility of creating well-defined experimental conditions represent 
the major strengths of this approach. However, such an approach has some weaknesses. 
Isolated mitochondria are removed from their natural environment and this may affect their 
functions. Therefore, it is important to verify data obtained with isolated mitochondria using 
more complex cell model of cultured primary neurons. In our previous studies, we examined 
oxidative metabolism and mitochondrial Ca2+ handling in cultured striatal neurons from 
YAC128 and FVB/NJ mice (Pellman et al., 2015; Hamilton et al., 2015). In the present 
study, we assessed respiration and Ca2+ uptake capacity in striatal nonsynaptic and synaptic 
mitochondria isolated from these mice. Although, two-month-old YAC128 mice already 
demonstrate clasping behavior, an early symptom associated with mHtt expression 
(Mangiarini et al., 1996; Reddy et al., 1999; Hamilton et al., 2015), our data obtained with 
cultured neurons and isolated mitochondria from YAC128 mice provide no evidence for 
mitochondrial impairment.
Mitochondrial respiration generates an electrochemical proton gradient across the 
mitochondrial inner membrane which is utilized to synthesize ATP in the process of 
oxidative phosphorylation and to transport Ca2+ into the mitochondrial matrix. 
Consequently, impairment of mitochondrial respiration may affect both oxidative 
phosphorylation and Ca2+ uptake. There are several reports suggesting mitochondrial 
respiratory deficits in various HD models (Tabrizi et al., 2000; Damiano et al., 2013; Aidt et 
al., 2013). However, our recent studies demonstrated the lack of defects in oxidative 
metabolism in mitochondria isolated from the whole HD brains and in cultured cortical and 
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striatal neurons derived from HD mice (Hamilton et al., 2015; Hamilton et al., 2016). In our 
current study, we did not find a difference in ADP-stimulated respiration and in uncoupled 
respiration stimulated by 2,4-DNP. This suggests that the oxidative phosphorylation system 
and electron transport chain are not affected by mHtt. Similar respiratory activities were 
observed with both malate plus pyruvate, Complex I substrates, and with succinate, a 
Complex II substrate. This suggests that Complex I and Complex II of electron transport 
chain are not impaired by mHtt. Our findings presented here are consistent with previously 
reported data. In early studies, Guidetti et al. did not detect alterations in activity of electron 
transport chain in the striatum and cerebral cortex of HD48 and HD89 mice, expressing full-
length mHtt with 48 or 89 glutamines, respectively, compared to wild-type mice (Guidetti et 
al., 2001). In experiments with cultured striatal neurons from 15–17 week-old heterozygous 
Hdh150 mice, cell respiratory activities were found to be similar (Oliveira et al., 2007). Olah 
et al. found that the activities of Complexes I–IV in brain mitochondria from 20-week-old 
transgenic N171-82Q mice were not diminished compared to mitochondria from wild-type 
animals (Olah et al., 2008). Gouarne et al. did not find a difference in respiration of cultured 
striatal neurons from heterozygous transgenic BACHD rats compared to wild-type neurons, 
when cells were incubated in the presence of 25 mM glucose and 1 mM pyruvate (Gouarne 
et al., 2013). In experiments with STHdhQ111/Q111 cells, mitochondrial pathways were not 
significantly altered and the obtained data uniformly refuted a view of direct deleterious 
mHtt effect on mitochondria (Lee et al., 2007). The direct measurements of oxidative 
metabolism in striatum of HD patients and age-matched controls using positron emission 
tomography failed to find a difference that argues against a defect in mitochondrial oxidative 
phosphorylation and mitochondrial electron transport chain activity (Powers et al., 2007). 
Finally, Ismailoglu et al. studied mouse embryonic stem cells expressing wild-type and 
140Q-mHtt and found no difference in cellular bioenergetics of these cell lines (Ismailoglu 
et al., 2014). Collectively, these results suggest the lack of overt respiratory defects in HD 
mitochondria.
A recent paper by Yano et al. described a series of well-designed experiments demonstrating 
inhibition of mitochondrial protein import machinery by mHtt that might lead to respiratory 
defects (Yano et al., 2014). However, the authors did not examine the levels of expression of 
nuclear-encoded mitochondrial proteins to demonstrate consequences of suppressed protein 
import into mitochondria. Moreover, the authors failed to detect a decrease in respiratory 
activity in mitochondria isolated from R6/2 mice (Yano et al., 2014). Although we did not 
assess activity of protein import machinery in striatal mitochondria from YAC128 mice, our 
data unequivocally demonstrate the lack of respiratory deficits and show the absence of 
alterations in protein expression in mitochondria from YAC128 mice. Taken together, these 
data suggest that if protein import in mitochondria of HD mice is suppressed, this, 
nevertheless, does not affect the level of expression of mitochondrial nuclear encoded 
proteins and, consequently, does not affect mitochondrial respiration.
Mitochondria possess Ca2+ channels, historically known as “calcium uniporter”, that allows 
Ca2+ influx into the mitochondrial matrix driven by high membrane potential, negative 
inside of the organelle (Bernardi, 1999). Inside of mitochondria, elevated Ca2+ can interact 
with inorganic phosphate and precipitate in the form of hydroxyapatite (Chalmers and 
Nicholls, 2003). This allows for the large Ca2+ accumulation in mitochondria. The ability of 
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mitochondria to accumulate significant amounts of Ca2+ is important for maintenance of 
Ca2+ homeostasis in the cell (Bernardi and Rasola, 2007). Ca2+ accumulation in 
mitochondria is limited by induction of the mitochondrial permeability transition pore that 
depolarizes mitochondria and prevents further Ca2+ uptake (Bernardi, 1999). In early 
studies, decreased Ca2+ uptake capacity in mitochondria isolated from HD mouse and cell 
models was reported, and it was proposed to contribute to HD pathogenesis by affecting 
Ca2+ homeostasis in neurons (Panov et al., 2002; Milakovic et al., 2006; Lim et al., 2008; 
Gellerich et al., 2008). However, other investigators failed to find a decrease in 
mitochondrial Ca2+ uptake capacity in mitochondria exposed to mHtt with an elongated 
polyQ stretch (Oliveira et al., 2007; De et al., 2016). In these studies, the authors either did 
not find a difference between mitochondria from HD and wild-type animals or they found a 
paradoxical increase in Ca2+ accumulation in mitochondria from HD mice. Our recent 
studies with nonsynaptic and synaptic mitochondria isolated from the whole brain of 
YAC128 and R6/2 mice and with cultured neurons from these animals substantiate these 
observations (Pellman et al., 2015; Hamilton et al., 2016). The results presented in this paper 
demonstrate the lack impairment of Ca2+ handling in nonsynaptic and synaptic mitochondria 
isolated from striata of YAC128 mice and support previous findings indicating the lack of 
Ca2+ accumulation defect in mitochondria from HD mice.
The experiments with isolated mitochondria and cultured neurons provide valuable 
information about possible effects of mHtt. However, in vivo measurements of brain 
respiratory activity may further enhance our understanding of potential defects in oxidative 
metabolism in HD. A recent paper by Lou et al. described elegant experiments with the use 
of 17O magnetic resonance spectroscopy aimed at assessing cerebral mitochondrial 
respiratory activity in R6/2 mice in vivo (Lou et al., 2016). In this study, the authors did not 
find a difference in basal striatal oxygen consumption rate in symptomatic R6/2 mice at rest. 
Inhibition of oxidative phosphorylation with oligomycin resulted in a similar decrease in 
respiration, suggesting similar phosphorylation capacity and coupling of oxidative 
phosphorylation in HD and wild-type mice. Yet, after injection of the uncoupler 2,4-DNP, 
the authors found a negligible (about 15%), but statistically significant, decrease in 
respiratory responses in both striatum and cortex of R6/2 mice compared with respiratory 
responses of corresponding brain tissues in wild-type animals (Lou et al., 2016). The 
physiological significance of this difference is not evident but it is clear that such conditions 
(2,4-DNP-induced stimulation) do not take place in real life. The ambiguity of the small 
difference in uncoupled respiration is supported by the fact that natural, sensory stimulation-
induced elevation in respiration measured with photoacoustical microscopy (Yao et al., 
2015) is weaker than 2,4-DNP-induced increase in oxygen consumption. Thus, importance 
and relevance of small decreases in 2,4-DNP stimulated respiration of mitochondria from 
HD mice is not obvious.
Overall, our current data obtained with striatal nonsynaptic and synaptic mitochondria from 
YAC128 mice and previously published data with whole-brain mitochondria and cultured 
striatal and cortical neurons from YAC128 and R6/2 mice (Pellman et al., 2015; Hamilton et 
al., 2015; Hamilton et al., 2016) do not provide evidence for mitochondrial respiratory 
deficiency and defects in mitochondrial Ca2+ handling. Other, mechanisms such as 
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alterations in mitochondrial dynamics, may play more important roles in HD pathogenesis 
and, consequently, may need greater attention.
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Highlights
• Respiration and Ca2+ capacity of striatal mitochondria from YAC128 mice 
were tested
• Mutant huntingtin failed to affect striatal mitochondrial respiration
• Mutant huntingtin did not alter expression of nuclear-encoded mitochondrial 
proteins
• Mutant huntingtin failed to diminish mitochondrial Ca2+ uptake capacity
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Figure 1. 
Clasping phenotype of 8-week-old YAC128 mouse and representative genotyping. (A) 
Typical response of a wild-type (WT) FVB/NJ mouse during suspension by the tail whereby 
the mouse maintains extension of the fore- and hind-limbs away from the body. (B) Usual 
clasping posture of an 8-week-old YAC128 mouse with retraction of the limbs toward the 
center of the body. (C) Representative genotyping data following PCR of DNA from tail 
tissue of WT and YAC128 mice.
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Figure 2. 
Purity of striatal nonsynaptic (Nonsynap) and synaptic (Synap) mitochondria isolated from 
FVB/NJ (A) and YAC128 (B) mice and detection of mHtt in mitochondrial fractions (C). In 
A and B, purity of striatal mitochondrial fraction was assessed by western blotting. 
Homogenates (Homogen), cytosolic, and mitochondrial fractions were analyzed using 
antibodies against calnexin (ER marker), MEK1/2 (cytosolic marker), and the 70 kDa 
subunit of Complex II (mitochondrial marker). In C, mHtt was detected as a single band 
exclusively in samples from YAC128 mice using the mouse monoclonal anti-polyQ antibody 
1C2. The 70 kDa subunit of Complex II was used as a mitochondrial marker and a loading 
control.
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Figure 3. 
Respiratory activity of striatal nonsynaptic mitochondria isolated from 2-month-old FVB/NJ 
(blue trace) and YAC128 (red trace) mice. In A, representative traces of oxygen 
consumption by striatal nonsynaptic mitochondria. Where indicated, mitochondria (30μg 
protein), 300μM ADP, or 60μM 2,4-dinitrophenol (2,4-DNP) were added. The incubation 
medium was supplemented with the Complex I substrates pyruvate (3 mM) plus malate (1 
mM). In B, the pooled group results demonstrating respiratory rates of striatal nonsynaptic 
mitochondria. Data are mean ± SEM, n = 5.
Hamilton et al. Page 17
Neurochem Int. Author manuscript; available in PMC 2018 October 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 4. 
Respiratory activity of striatal nonsynaptic and synaptic mitochondria isolated from 2-
month-old FVB/NJ (blue traces) and YAC128 (red traces) mice. Representative traces of 
oxygen consumption by either striatal nonsynaptic (A) or striatal synaptic (B) mitochondria. 
Where indicated, mitochondria (30μg protein), 200μM ADP, or 60μM 2,4-dinitrophenol 
(2,4-DNP) were added. The incubation medium was supplemented with the Complex II 
substrate succinate (3mM) plus glutamate (3mM). Additionally, incubation medium was 
supplemented with 0.1% BSA (free from fatty acids) to maintain mitochondrial integrity 
(Lai and Clark, 1989). The pooled group results demonstrating respiratory rates are shown 
for striatal nonsynaptic (C) and striatal synaptic (D) mitochondria. Data are mean ± SEM, n 
= 5 (nonsynaptic), n = 4 (synaptic).
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Figure 5. 
Expression of nuclear encoded mitochondrial proteins in nonsynaptic and synaptic striatal 
mitochondria derived from FVB/NJ and YAC128 mice. In A and C, are representative 
western blots of nonsynaptic and synaptic striatal mitochondria isolated from FVB/NJ and 
YAC128 mice probed with various antibodies against nuclear-encoded mitochondrial 
proteins including 39 kDa subunit of Complex I, 30 and 70 kDa subunits of Complex II, 
Aconitase 2, Mn-dependent superoxide dismutase (Mn-SOD), α subunit of ATP synthase, 
cyclophilin D (CyD), and cytochrome oxidase subunit IV (COX IV). Voltage-dependent 
anion channel isoform 1 (VDAC1) was used as a loading control. In B and D, the results of 
densitometry performed with NIH ImageJ 1.48v software. Data are mean ± SEM, n = 6.
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Figure 6. 
Ca2+ uptake capacity of brain nonsynaptic mitochondria isolated from the striatum of 
FVB/NJ (blue traces) and YAC128 (red traces) mice. Mitochondrial Ca2+ uptake capacity 
was measured in the standard incubation medium supplemented with the Complex I 
substrates pyruvate (3 mM) and malate (1 mM) (A), or the Complex II substrate succinate 
plus glutamate (both in 3 mM) (B). In C, in addition to succinate plus glutamate, the 
incubation medium was supplemented with 0.1% BSA (free from fatty acids). In all 
experiments, the incubation medium was also supplemented with 100μM ADP and 1μM 
oligomycin (Chalmers and Nicholls, 2003). Where indicated, 10μM Ca2+ pulses (delivered 
as CaCl2) were applied to mitochondria until mitochondria were unable to accumulate 
additional Ca2+ and released previously accumulated Ca2+. In D, the pooled group results 
demonstrating Ca2+ uptake capacity of striatal nonsynaptic mitochondria from FVB/NJ and 
YAC128 mice. Data are mean ± SEM, n = 4.
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Figure 7. 
Ca2+ uptake capacity of brain synaptic mitochondria isolated from the striatum of FVB/NJ 
(blue traces) and YAC128 (red traces) mice. Mitochondrial Ca2+ uptake capacity was 
measured in the standard incubation medium supplemented with the Complex II substrate 
succinate (3 mM) plus glutamate (3 mM) in the absence (A) or presence of 0.1% BSA (B). 
In all experiments, the incubation medium was also supplemented with 100μM ADP and 
1μM oligomycin (Chalmers and Nicholls ,2003). Where indicated, 10μM Ca2+ pulses 
(delivered as CaCl2) were applied to mitochondria until mitochondria were unable to 
accumulate additional Ca2+ and released previously accumulated Ca2+. In C, the pooled 
group results showing Ca2+ uptake capacity of striatal synaptic mitochondria from FVB/NJ 
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and YAC128 mice. Data are mean ± SEM, *p<0.05 comparing mitochondria from YAC128 
and FVB/NJ mice in the presence of 0.1% BSA, n = 5.
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